Teva’s Shrinking U.S. Footprint Blockbusters, Contraception, FDA, Fertility, Generics, Job Cuts, Menopause, Office Closings, Osteoporosis, Real Estate, Reorganization/Restructuring Teva Pharmaceuticals Inc. made more cuts in the United States, this time to real estate holdings. To save money, the company will close its offices in Washington, D.C. and New York City. No jobs were reported to be lost from the cuts. Read more February 23, 2018/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2018-02-23 12:27:222018-02-23 13:26:07Teva's Shrinking U.S. Footprint